trending Market Intelligence /marketintelligence/en/news-insights/trending/i792fsk8jo4-i2rkr5l2sa2 content esgSubNav
In This List

Bellicum appoints chief medical officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Bellicum appoints chief medical officer

Bellicum Pharmaceuticals Inc. appointed William Grossman as chief medical officer, effective Feb. 5.

Most recently, Grossman served as the group medical director of cancer immunotherapy at Genentech Inc., a unit of Roche Holding AG.